Immunostimulant In Situ Hydrogel Improves Synergetic Radioimmunotherapy of Malignant Glioblastoma Relapse Post‐Resection
Shuo Sun(Nanjing Brain Hospital), Yun Chen(Jiangsu Cancer Hospital), Hong Xiao(Nanjing Medical University), Qianqian Zhao(Nanjing Medical University), Kun Yang(Taian City Central Hospital), Chupeng Hu(Jiangsu Cancer Hospital), Jian Liu(Nantong University), Jing Ji(Jiangsu Province Hospital), Haisi Wu(Nanjing Medical University), Hongyi Liu(Fudan University Shanghai Cancer Center), Yu Jin(Nanjing Medical University), Wei Gu(Jiangsu Province Hospital), Shiyu Qian(Nanjing Medical University), Huae Xu(Nanjing Medical University), Ye Gao(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 52
Related Papers
Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer
|Nucleic Acids Research|2020|228
Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC
|Hepatology|2022|181
Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury
|Nature Communications|2021|140
Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1
|Cell Death and Disease|2022|123
Gastric Microbiome Alterations Are Associated with Decreased CD8+ Tissue-Resident Memory T Cells in the Tumor Microenvironment of Gastric Cancer
|Cancer Immunology Research|2022|120